MoonLake Immunotherapeutics (MLTX) Stock Chart & Stock Price History → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free MLTX Stock Alerts $43.25 +2.23 (+5.44%) (As of 04/23/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media MoonLake Immunotherapeutics Stock Price Performance5 Day Performance+2.51%1 Month Performance-16.83%3 Month Performance-23.02%6 Month Performance-18.64%Year-To-Date Performance-28.38%1 Year Performance+81.27% Receive MLTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MoonLake Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. MLTX Stock Chart for Wednesday, April, 24, 2024 MLTX Chart by TradingView MoonLake Immunotherapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$41.02$43.25+5.44%$43.26$41.45579,345 shs$2.76 billion04/22/2024$42.19$41.02-2.77%$42.51$40.72276,685 shs$2.62 billion04/19/2024$42.25$42.19-0.14%$42.80$40.68527,548 shs$2.70 billion04/18/2024$43.51$42.25-2.90%$43.69$42.16228,086 shs$2.78 billion04/17/2024$43.50$43.51+0.02%$43.88$43.45266,188 shs$2.78 billion04/16/2024$43.64$43.50-0.32%$43.87$43.14284,704 shs$2.78 billion Get the Latest News and Ratings for MLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MoonLake Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$43.91$43.64-0.61%$44.17$42.64340,143 shs$2.79 billion04/12/2024$45.65$43.91-3.81%$45.92$43.35438,772 shs$2.81 billion04/11/2024$46.18$45.65-1.15%$47.17$44.84237,557 shs$2.92 billion04/10/2024$46.75$46.18-1.22%$47.09$45.89290,537 shs$2.95 billion04/09/2024$46.27$46.75+1.04%$47.11$45.63373,111 shs$2.99 billion04/08/2024$47.17$46.27-1.91%$47.72$46.04332,166 shs$2.96 billion04/05/2024$45.99$47.17+2.57%$47.70$45.69584,672 shs$3.01 billion04/04/2024$45.97$45.99+0.04%$46.68$45.71552,116 shs$2.94 billion04/03/2024$47.25$45.97-2.71%$48.24$45.83380,628 shs$2.94 billion04/02/2024$48.60$47.25-2.78%$48.37$47.11459,726 shs$3.02 billion04/01/2024$50.23$48.60-3.25%$50.28$48.04372,359 shs$3.11 billion03/29/2024$50.23$50.23$52.92$48.701.17 million shs$3.21 billion03/28/2024$50.21$50.23+0.04%$52.92$48.701.17 million shs$3.21 billion03/27/2024$50.08$50.21+0.26%$50.88$48.71389,780 shs$3.21 billion03/26/2024$51.74$50.08-3.21%$53.11$49.94256,307 shs$3.20 billion03/25/2024$52.00$51.74-0.50%$53.99$51.02780,614 shs$3.31 billion03/22/2024$52.37$52.00-0.71%$52.98$51.06310,923 shs$3.32 billion03/21/2024$49.50$52.37+5.80%$52.47$49.56467,429 shs$3.35 billion03/20/2024$50.59$49.50-2.15%$50.82$48.41285,787 shs$3.16 billion03/19/2024$48.56$50.59+4.18%$51.86$48.48600,772 shs$3.23 billion03/18/2024$47.25$48.56+2.77%$51.78$47.25792,909 shs$3.10 billion03/15/2024$43.78$47.25+7.93%$47.63$43.09775,324 shs$3.02 billion03/14/2024$44.90$43.78-2.49%$44.70$42.44510,692 shs$2.80 billion03/13/2024$46.04$44.90-2.48%$46.66$44.49563,700 shs$2.87 billion03/12/2024$47.05$46.04-2.15%$47.63$45.47552,672 shs$2.94 billion03/11/2024$45.61$47.05+3.16%$49.30$45.16995,222 shs$3.01 billion03/08/2024$45.58$45.61+0.07%$46.79$45.06588,563 shs$2.85 billion03/07/2024$45.21$45.58+0.82%$45.98$44.73330,815 shs$2.85 billion03/06/2024$48.10$45.21-6.01%$48.54$44.60351,973 shs$2.82 billion03/05/2024$48.86$48.10-1.56%$50.26$47.46302,652 shs$3.00 billion03/04/2024$50.92$48.86-4.05%$51.62$48.40424,076 shs$3.05 billion03/01/2024$48.24$50.92+5.56%$52.48$49.31824,254 shs$3.18 billion02/29/2024$56.81$48.24-15.09%$57.55$47.081.79 million shs$3.01 billion02/28/2024$54.76$56.81+3.74%$57.36$54.36639,093 shs$3.55 billionElon Musk’s Controversial New Project: “Apollo” (Ad)Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake.02/27/2024$52.12$54.76+5.07%$55.00$51.85774,142 shs$3.42 billion02/26/2024$52.05$52.12+0.13%$53.40$50.65647,097 shs$3.25 billion02/23/2024$52.21$52.05-0.31%$53.32$52.00340,309 shs$3.25 billion02/22/2024$53.55$52.21-2.50%$54.95$52.11406,777 shs$3.26 billion02/21/2024$55.20$53.55-2.99%$55.87$52.67479,176 shs$3.34 billion02/20/2024$59.92$55.20-7.88%$59.35$55.00539,128 shs$3.45 billion02/19/2024$59.92$59.92$61.17$59.20644,000 shs$3.74 billion02/16/2024$60.03$59.92-0.18%$61.17$59.20643,902 shs$3.74 billion02/15/2024$62.50$60.03-3.95%$64.00$58.02676,787 shs$3.75 billion02/14/2024$62.99$62.50-0.78%$63.22$61.50215,194 shs$3.90 billion02/13/2024$63.86$62.99-1.36%$64.00$62.31289,189 shs$3.93 billion02/12/2024$63.19$63.86+1.06%$64.98$62.76261,695 shs$3.99 billion02/09/2024$61.25$63.19+3.17%$64.48$61.50347,397 shs$3.95 billion02/08/2024$59.91$61.25+2.24%$61.54$59.81305,611 shs$3.83 billion02/07/2024$58.59$59.91+2.25%$60.26$58.05304,762 shs$3.74 billion02/06/2024$58.86$58.59-0.46%$59.80$57.17497,906 shs$3.66 billion02/05/2024$55.25$58.86+6.53%$58.98$54.59301,275 shs$3.68 billion02/02/2024$57.02$55.25-3.10%$56.98$54.44396,332 shs$3.45 billion02/01/2024$55.88$57.02+2.04%$60.80$55.56626,176 shs$3.56 billion01/31/2024$56.50$55.88-1.10%$56.44$55.42379,808 shs$3.49 billion01/30/2024$58.17$56.50-2.87%$58.18$56.11361,241 shs$3.53 billion01/29/2024$57.18$58.17+1.73%$58.22$56.94221,448 shs$3.63 billion01/26/2024$56.71$57.18+0.83%$57.73$55.98273,530 shs$3.57 billion01/25/2024$56.18$56.71+0.94%$58.37$56.25361,156 shs$3.54 billion01/24/2024$56.48$56.18-0.53%$57.28$55.54213,427 shs$3.51 billion01/23/2024$55.40$56.48+1.95%$57.07$55.01270,998 shs$3.53 billion Related Companies: ACAD Stock Chart MOR Stock Chart INDV Stock Chart HCM Stock Chart ARWR Stock Chart JANX Stock Chart IDYA Stock Chart EVO Stock Chart SMMT Stock Chart FOLD Stock Chart Receive MLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MoonLake Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MLTX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MoonLake Immunotherapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.